The global mammography ecosystem is entering a phase of rapid transformation driven by technology upgrades, rising disease burden, and stronger focus on early detection. Breast cancer continues to be one of the most commonly diagnosed cancers worldwide, and this is directly influencing diagnostic infrastructure planning across hospitals, imaging centers, and specialty clinics. As a result, the global mammography market size is projected to reach USD 4,673.2 million by 2030, expanding at a CAGR of 10.5% from 2025 to 2030. The sustained growth reflects a clear shift toward preventive screening and precision-based diagnostic workflows.

A major driver behind this expansion is the increasing demand for early-stage diagnosis amongst patients. Healthcare systems are placing greater emphasis on detecting abnormalities at the earliest possible stage, where treatment outcomes are significantly improved and cost burdens are reduced. In parallel, the rising prevalence of breast cancer across both developed and emerging regions is pushing demand for advanced mammography devices capable of delivering higher accuracy, faster imaging, and improved patient comfort.

Technology Evolution Reshaping Mammography Systems

The current wave of innovation in mammography is strongly influenced by digital transformation and intelligent imaging systems. Artificial intelligence is increasingly being integrated into screening workflows, acting as a secondary reader to support radiologists in identifying subtle lesions and reducing diagnostic variability. This shift is improving detection efficiency while also optimizing radiologist workload, which is becoming critical as screening volumes continue to rise globally.

Another important trend is the development of faster, low-dose, and patient-friendly imaging platforms. Modern systems are now designed to minimize discomfort during compression while maintaining high image resolution. In addition, the move toward 3D mammography (digital breast tomosynthesis) is gaining momentum as it allows layered imaging of breast tissue, improving detection accuracy in dense breast cases.

Recent innovations from leading manufacturers highlight this competitive momentum. In November 2024, GE HealthCare introduced the Pristina Via mammography system, designed to enhance both patient experience and technologist workflow. This system builds on the Senographe Pristina platform and includes vendor-neutral prior image comparison along with reduced radiation exposure across varying breast densities. In the same period, Hologic Inc. launched the Envision Mammography Platform at RSNA, offering high-speed 3D mammography with scan times as low as 2.5 seconds, significantly improving screening throughput.

Training and skill development are also becoming integral to technology adoption. In June 2024, FUJIFILM’s India Healthcare Division partnered with NM Medical Mumbai to establish a dedicated Skill Lab focused on full-field digital mammography. This initiative aims to enhance the capabilities of radiographers and radiologists, ensuring effective utilization of advanced imaging systems.

Competitive Landscape and Key Participants

The mammography market is characterized by the presence of several established global manufacturers who continue to shape technological direction and product innovation. These companies collectively hold a significant share of the market and influence industry standards through continuous research and development.

Key mammography companies include:

• Hologic Inc.
• Analogic Corporation
• CANON MEDICAL SYSTEMS CORPORATION
• FUJIFILM Corporation
• Siemens Healthcare Private Limited
• Toshiba
• GE HealthCare
• Metaltronica S.p.A
• Koninklijke Philips N.V.
• Planmed Oy

These organizations are actively investing in advanced imaging modalities, workflow automation, and AI-driven diagnostic support systems. Their focus is not only on improving image quality but also on reducing examination time, enhancing patient comfort, and enabling scalable screening programs across diverse healthcare settings.

Future Outlook Driven by Access and Precision Screening

The future trajectory of mammography is expected to be shaped by three core pillars: accessibility, precision, and intelligence. Expanding screening access through mobile diagnostic units and community-based programs is helping bridge gaps in underserved regions. At the same time, risk-based and personalized screening models are gradually replacing uniform screening schedules, ensuring that high-risk populations receive more frequent and targeted imaging.

As technology continues to mature, mammography systems are expected to become more automated, more accurate, and more integrated with broader diagnostic ecosystems. With strong market growth projections and continuous innovation from leading manufacturers, the sector is positioned for sustained expansion through 2030, reinforcing its critical role in early cancer detection and preventive healthcare strategies.